Syngen Biotech Co.,Ltd. (TPEX:8279)

Syngen Biotech Revenue

Syngen Biotech had revenue of 563.22M TWD in the quarter ending September 30, 2025, with 1.38% growth. This brings the company's revenue in the last twelve months to 2.13B, up 6.55% year-over-year. In the year 2024, Syngen Biotech had annual revenue of 2.01B with 9.60% growth.

• Revenue (ttm): 2.13B
• Revenue Growth: +6.55%
• P/S Ratio: 1.65
• Revenue / Employee: 8.63M
• Employees: 247
• Market Cap: 3.52B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.01B	176.41M	9.60%
Dec 31, 2023	1.84B	-93.41M	-4.84%
Dec 31, 2022	1.93B	459.33M	31.22%
Dec 31, 2021	1.47B	159.83M	12.19%
Dec 31, 2020	1.31B	14.17M	1.09%